The Business Development & Strategy Team at Fred Hutch has a stellar track record of finding partners who share our drive to innovate, collaborate and accelerate the development of high-impact technologies and therapies. The result has been dozens of licensing agreements, strategic partnerships, spinouts and startups, including such high-profile launches as Juno Therapeutics, Adaptive Biotechnologies, Nohla Therapeutics and Faraday Pharmaceuticals.
The Lampe Lab at Fred Hutch has identified and validated a five-protein panel for early detection of colon cancer and adenoma. Two independent studies have confirmed this biomarker panel. Colon cancer is the third-leading cause of cancer-related deaths in the U.S.; about 150,000 new cases are diagnosed each year. Early detection dramatically increases the odds of survival.
The pioneering immunotherapy company Juno Therapeutics was founded in 2013 as a partnership between Fred Hutch, Memorial Sloan-Kettering Cancer Research Center and Seattle Children’s Research Institute, licensing cutting-edge research from all three institutions. It launched with $120 million in private investment funding, making it one of the largest biotech startups in history. Juno initially targeted blood cancers but has expanded its focus to include some solid-tumor cancers, such as colorectal cancer and certain sarcomas, in further partnership with Fred Hutch investigators.
We provide state-of-the-art data infrastructure and data science support for our investigators in areas such as data mining, machine learning, mobile app development and bioinformatics.Learn More
We maintain our own 37,000-square-foot facility that produces high-quality stem cell products for research, clinical trials and therapeutic use.
Fred Hutch researchers are eligible to apply for special funding to help them take their discoveries and ideas to a commercially viable stage.
We’re tackling cancer from every angle in our research labs and in collaborative projects that span the globe.
We offer a breadth of leading-edge treatments, some not available elsewhere — plus the opportunity to participate in clinical trials.
Our pioneering research has saved hundreds of thousands of lives worldwide. Learn more about our vision, values and global reach.
Learn how your support for Fred Hutch can help provide cancer patients with the most precious gift of all: time.